These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Ten-year mortality from Creutzfeldt-Jakob disease in Cyprus. Papacostas S; Malikides A; Petsa M; Kyriakides T East Mediterr Health J; 2008; 14(3):715-9. PubMed ID: 18720636 [TBL] [Abstract][Full Text] [Related]
43. Creutzfeldt-Jakob disease presenting with alien limb sign. Fogel B; Wu M; Kremen S; Murthy K; Jackson G; Vanek Z Mov Disord; 2006 Jul; 21(7):1040-2. PubMed ID: 16552737 [TBL] [Abstract][Full Text] [Related]
44. [Early and differential diagnosis of Creutzfeldt-Jakob disease]. Zerr I; Mollenhauer B; Werner Ch; Poser S Dtsch Med Wochenschr; 2002 Feb; 127(7):323-7. PubMed ID: 11845388 [No Abstract] [Full Text] [Related]
45. [Progressive myoclonic cerebellar ataxia as a manifestation of Creutzfeldt-Jakob disease]. Santos S; Pascual-Millán LF; Escalza-Codina I; Navas-Vinagre I; López del Val LJ; Mostacero-Miguel E; Ramón y Cajal S Rev Neurol; 2003 Sep 16-30; 37(6):535-8. PubMed ID: 14533072 [TBL] [Abstract][Full Text] [Related]
46. Creutzfeldt-Jakob disease presenting as refractory nonconvulsive status epilepticus. Fernández-Torre JL J Intensive Care Med; 2005; 20(3):180-1; author reply 182. PubMed ID: 15888907 [No Abstract] [Full Text] [Related]
47. Transplantation and CID: ethical concerns. Davies H Br J Nurs; 1998 Jan 22-Feb 11; 7(2):111. PubMed ID: 9510687 [No Abstract] [Full Text] [Related]
48. French doctors are tried for treating children with infected growth hormone. Spurgeon B BMJ; 2008 Feb; 336(7640):348-9. PubMed ID: 18276693 [No Abstract] [Full Text] [Related]
49. A mystery disease. Stephen H Nurs Stand; 1999 May 5-11; 13(33):12-3. PubMed ID: 10427167 [No Abstract] [Full Text] [Related]
50. [Firm routines are necessary for transportation of foreign patients to their home]. Durling H Lakartidningen; 1991 Sep; 88(39):3205-6. PubMed ID: 1921617 [No Abstract] [Full Text] [Related]
51. [Lack of commitment and cooperation]. Lakartidningen; 1977 Jan; 74(1-2):45. PubMed ID: 831030 [No Abstract] [Full Text] [Related]
52. Creutzfeldt-Jakob disease and the eye. I. Background and patient management. Lueck CJ; McIlwaine GG; Zeidler M Eye (Lond); 2000 Jun; 14 ( Pt 3A)():263-90. PubMed ID: 11026987 [TBL] [Abstract][Full Text] [Related]
53. [Deficient routines in management of Creutzfeldt-Jakob disease]. Liungman O Lakartidningen; 2000 Aug; 97(35):3781-2. PubMed ID: 11016236 [No Abstract] [Full Text] [Related]
54. [Patients with Creutzfeldt-Jakob syndrome are screened. So far 122 cases discovered in Sweden]. Lundberg PO Lakartidningen; 1997 Oct; 94(43):3831-3. PubMed ID: 9411141 [No Abstract] [Full Text] [Related]
55. [The National Board of Health and Welfare on Creutzfeldt-Jakob disease: physicians are to be notified about suspected cases]. Tüll P Lakartidningen; 2000 Sep; 97(37):4045. PubMed ID: 11036368 [No Abstract] [Full Text] [Related]
56. Nursing patients with Creutzfeldt-Jakob disease. Are you at risk? Stride P; Hunter J; Bailey M Aust Nurs J; 2009 Jul; 17(1):30-2. PubMed ID: 19678487 [No Abstract] [Full Text] [Related]